US-based imaging-guided therapy provider Astute acquires Egyptian DilenyTech

EGYPT – Astute Imaging LLC, a US-based imaging-guided therapy provider, has announced the acquisition of DilenyTech, a Cairo-based healthtech and AI-powered deep technology screening company for an undisclosed value.

Dileny Technology (DilenyTech) is a cutting-edge startup that develops and deploys cutting-edge AI technologies to help radiologists perform more efficiently.

It focuses on medical imaging analytic applications, risk assessment for breast cancer, and structured reporting for a variety of medical applications.

Astute Imaging will be able to use AI to improve its present offering, extend services, and develop new medical imaging solutions as a result of the acquisition.

The company is focusing on adopting state-of-the-art AI and cloud technologies to advance its unique patented imaging software and enable precision medicine for healthcare providers and device companies.

DilenyTech developed several vendor-neutral AI proprietary technologies for radiology workflow with a special focus on women’s health.

The company was recently granted a US patent for its novel AI technology in medical imaging and provided its services to top-tier international healthcare companies and medical organizations.

 “This strategic acquisition of DilenyTech will enable Astute Imaging to expedite the development of an AI-driven image-guided therapy platform and add more automation to our imaging services and procedure planning solutions,” said Wael Elseaidy, co-founder and CEO of Astute Imaging.

Astute Imaging is planning to launch an AI-powered tracking application for the aorta to provide proactive patient-centric services for providers.

In addition, the company is planning to enable its imaging core lab and procedure planning services with AI to allow seamless workflow and device tracking for the medical device industry.

This acquisition will help Astute Imaging to expedite the introduction of AI into its cloud-based platform for image-guided therapy and workflow automation utilizing millions of procedure data assets to drive faster and enhanced services,” said Ewald de Vries, co-founder, and Astute imaging CTO.

Astute imaging is also planning to develop and offer predictive models for cardiovascular case planning and to expand into other areas such as women’s health, and cancer treatments.

Predictive models will help companies to get better insights about future enhancements for interventional devices for image-guided procedures, especially in the cardiovascular and cancer domains.

Liked this article? Subscribe to DealStreet Africa News, our regular email newsletter with the latest news, deals, and insights from Africa’s business, economy, and more. SUBSCRIBE HERE

Other Recent Posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.